PATENT CLAIM ANALYSIS

Application Number: 15913233
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["435", "006000"]

Abstract:
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of an Adiponectin (ADIPOQ), in particular, by targeting natural antisense polynucleotides of an Adiponectin (ADIPOQ). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of Adiponectins (ADIPOQ)s.

Claim (Index 11):
The method of  claim 1  or  2 , wherein the at least one oligonucleotide comprises at least one oligonucleotide sequences set forth as SEQ ID NOS: 24 to 31.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.65
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13388782', '15050577', '14696392', '13695801', '14701998']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8092611020360678
- 35 USC 102 Novelty (BERT): 0.6551123838601041
- Combined Prediction Score: 0.7938462302184714
- Mean Citation Score: 693.699324
- Max Citation Score: 755.0941
- Similarity Product: 592.9123991541147

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test